STOCK TITAN

Twist Bioscience Corporation - TWST STOCK NEWS

Welcome to our dedicated page for Twist Bioscience Corporation news (Ticker: TWST), a resource for investors and traders seeking the latest updates and insights on Twist Bioscience Corporation stock.

Twist Bioscience Corporation, symbol TWST, stands at the forefront of synthetic biology with an innovative approach to DNA synthesis. The company's core expertise lies in developing a proprietary semiconductor-based synthetic DNA manufacturing process. This process utilizes a unique 10,000-well silicon platform, markedly different from the traditional 96-well plastic plates. This advanced platform enables the production of synthetic biology tools, such as oligonucleotides, genes, pathways, chassis, and genomes, in a more efficient, cost-effective, and high-throughput manner.

The implications of Twist Bioscience's technology are profound, offering the potential to revolutionize various fields. By synthesizing DNA on silicon, the company overcomes existing production inefficiencies, ensuring rapid and high-quality DNA synthesis. This capability is crucial for accelerating developments in personalized medicine, sustainable chemical production, agricultural improvements, in vivo diagnostics, biodetection, and even data storage.

Based primarily in the United States, Twist Bioscience derives the majority of its revenue from its home market. The company's strategic partnerships and ongoing projects reflect its commitment to pioneering advancements in synthetic biology. Having positioned itself as a leader in the field, Twist Bioscience continues to support researchers and industries by providing high-quality synthetic DNA rapidly, enabling them to seize emerging opportunities.

For more information, please visit Twist Bioscience.

Rhea-AI Summary
Twist Bioscience Corporation (NASDAQ: TWST) announces participation in the 6th Annual Evercore ISI HealthCONx Conference. CEO Emily M. Leproust and CFO Jim Thorburn will engage in a fireside chat on November 28 at 7:30 a.m. Eastern Time in Miami, FL. The webcast will be available on the company's investor relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.31%
Tags
conferences
-
Rhea-AI Summary
Twist Bioscience Corporation (NASDAQ: TWST) announces grant of 130,400 restricted stock units to 15 new hires. The RSUs vest over a 48-month period, in accordance with Nasdaq rules.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.61%
Tags
none
-
Rhea-AI Summary
Twist Bioscience Corporation (NASDAQ: TWST) will release its financial results for the fiscal 2023 fourth quarter and full year on November 17, 2023. The company will hold a conference call and live webcast at 8:00 a.m. Eastern Time to discuss the results and provide a business update. The press release and webcast will be accessible from the company's website. Telephone participants must register in advance to receive the dial-in number and PIN. Webcast replay will be available for two weeks.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.8%
Tags
conferences earnings
Rhea-AI Summary
Twist Bioscience launches Twist Full Length Unique Dual Index Adapters for PCR-free whole genome sequencing and multiplexing. The adapters streamline library preparation, reduce hands-on time, and eliminate PCR-related errors. They come with 1536 barcoded indexes for tracking individual samples, allowing researchers to run up to 1536 samples in a single sequencing run. Twist will showcase the new offering at the ASHG 2023 conference.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.51%
Tags
none
-
Rhea-AI Summary
Twist Bioscience announces antibody discovery agreement with Bayer
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.43%
Tags
none
-
Rhea-AI Summary
Twist Bioscience appoints Mark Buck as SVP of Operations, bringing experience in improving manufacturing efficiency and driving revenue. The company is making excellent progress in preparation for the launch of fast genes in November, with a current median production turnaround time of six business days. Buck's expertise and strategic guidance will help expand the company's reach and market share globally.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.17%
Tags
management
Rhea-AI Summary
Twist Bioscience and IMIDomics announce a multi-program collaboration for antibody discovery activities against IMID targets. Twist will receive upfront and project-specific fees, milestone payments, and royalties. IMIDomics will receive human antibodies from Twist.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.37%
Tags
none
-
Rhea-AI Summary
Twist Bioscience CEO to participate in investor conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.55%
Tags
conferences
-
Rhea-AI Summary
Twist Bioscience announces drug discovery agreement with Ono Pharmaceutical to develop novel antibodies for autoimmune diseases.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.48%
Tags
none
Rhea-AI Summary
Twist Bioscience releases ESG report for 2023, highlighting sustainability and carbon footprint reduction.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.93%
Tags
none

FAQ

What is the current stock price of Twist Bioscience Corporation (TWST)?

The current stock price of Twist Bioscience Corporation (TWST) is $41.66 as of November 21, 2024.

What is the market cap of Twist Bioscience Corporation (TWST)?

The market cap of Twist Bioscience Corporation (TWST) is approximately 2.4B.

What does Twist Bioscience Corporation do?

Twist Bioscience specializes in synthetic DNA production, utilizing a proprietary semiconductor-based platform to create high-quality DNA efficiently.

How does Twist Bioscience's technology differ from traditional methods?

Twist Bioscience uses a 10,000-well silicon platform instead of traditional 96-well plastic plates, offering faster, cost-effective, and high-throughput DNA synthesis.

What are some applications of Twist Bioscience's synthetic DNA?

Applications include personalized medicine, sustainable chemical production, improved agriculture, in vivo diagnostics, biodetection, and data storage.

Where does Twist Bioscience generate most of its revenue?

Twist Bioscience primarily generates its revenue from the United States.

How does Twist Bioscience contribute to personalized medicine?

By providing rapid and high-quality DNA synthesis, Twist Bioscience accelerates the development of personalized medical treatments.

What is the significance of using silicon in DNA synthesis?

Using silicon allows Twist Bioscience to overcome inefficiencies in traditional DNA production, enabling faster and more cost-effective synthesis.

Can Twist Bioscience's technology be used in agriculture?

Yes, the synthetic DNA tools can improve agricultural production by enabling the development of better crops and agricultural methods.

What ongoing projects does Twist Bioscience have?

Twist Bioscience is involved in various projects across personalized medicine, sustainable chemical production, and new applications such as in vivo diagnostics and data storage.

How does Twist Bioscience's platform support researchers?

The platform provides researchers with high-throughput, high-quality synthetic DNA, enabling them to quickly explore and develop new opportunities.

Where can I find more information about Twist Bioscience?

Additional information is available on their official website: www.twistbioscience.com.

Twist Bioscience Corporation

Nasdaq:TWST

TWST Rankings

TWST Stock Data

2.41B
58.13M
1.94%
110.12%
15.4%
Diagnostics & Research
Biological Products, (no Disgnostic Substances)
Link
United States of America
SOUTH SAN FRANCISCO